The Chronic Myeloid Leukemia Stem Cell
- 1 December 2009
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 9, S376-S381
- https://doi.org/10.3816/clm.2009.s.037
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- IFNα activates dormant haematopoietic stem cells in vivoNature, 2009
- An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsBlood, 2007
- Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)Blood, 2007
- FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemiaJCI Insight, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2006
- Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylateBlood, 2006
- Dynamics of chronic myeloid leukaemiaNature, 2005
- Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pumpBlood, 2004
- Chronic Myeloid LeukemiaThe New England Journal of Medicine, 1999
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997